The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Specific, major histocompatibility complex-unrestricted recognition of tumor-associated mucins by human cytotoxic T cells.
Open accessAbstract
We have previously reported the establishment of cytotoxic T-cell lines from pancreatic cancer patients, by continuously stimulating tumor-draining lymph node cells with allogeneic pancreatic tumor cell lines. After the preliminary characterization of their phenotype and tumor specificity, detailed studies performed with one of the cell lines, W.D., show that it recognizes a specific antigen, a large and heavily glycosylated mucin molecule, expressed on pancreatic and breast tumors and tumor cell lines. Although this recognition appears major histocompatibility complex (MHC)-unrestricted, the antigen receptor used by the cytotoxic T cell is the alpha/beta heterodimer, typically found on MHC-restricted T cells. The target antigen is atypical, however, in its ability to directly bind and activate the T cells in the absence of self MHC, presumably by abundant and regularly repeated antigenic epitopes. These findings are important because they demonstrate a specific T-cell response against a human tumor-associated antigen. In addition to pancreatic and breast tumors, various mucin molecules are known to be produced by other tumors of epithelial cell origin and could be expected to stimulate similar T-cell-mediated immune responses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
Raza, H., John, A., & Nemmar, A. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350087 · Cited by 47,221
ZINKERNAGEL, R. M., & DOHERTY, P. C. (1974) · Nature · doi:10.1038/248701a0 · Cited by 2,095
Gendler, S., Taylor-Papadimitriou, J., Duhig, T., Rothbard, J., & Burchell, J. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)37632-4 · Cited by 568
Molecular Cloning of Human Intestinal Mucin cDNAs
Gum, J. R., Byrd, J. C., Hicks, J. W., Toribara, N. W., Lamport, D. T. A., & Kim, Y. S. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83373-7 · Cited by 541
Burchell, J., Gendler, S. J., Taylor‐Papadimitriou, J., Girling, A. C., Lewis, A., Millis, R. R., & Lamport, D. T. A. (1987) · PubMed · Cited by 514
Isolation and sequencing of a cDNA coding for the human DF3 breast carcinoma-associated antigen.
Siddiqui, J., Abe, M., Hayes, D., Shani, E., Yunis, E., & Kufe, D. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.7.2320 · Cited by 308
Mitchell, M. S., Kan‐Mitchell, J., Kempf, R. A., Harel, W., Shau, H., & Lind, S. (1988) · PubMed · Cited by 255
Antigens of human pancreatic adenocarcinoma cells defined by murine monoclonal antibodies.
Metzgar, R. S., Gaillard, M. T., Levine, S. J., Tuck, F. L., Bossen, E. H., & Borowitz, M. J. (1982) · PubMed · Cited by 246
Self-citationMetzgar, R. S., Rodriguez, N., Finn, O. J., Lan, M. S., Daasch, V. N., Fernsten, P. D., Meyers, W. C., Sindelar, W. F., Sandler, R. S., & Seigler, H. F. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.16.5242 · Cited by 154
Self-citation
Cited by
Gendler, S. J., & Spicer, A. P. (1995) · Annual Review of Physiology · doi:10.1146/annurev.ph.57.030195.003135 · Cited by 979
Molecular cloning and expression of human tumor-associated polymorphic epithelial mucin.
Gendler, S. J., Lancaster, C. A., Taylor-Papadimitriou, J., Duhig, T., Peat, N., Burchell, J., Pemberton, L., Lalani, E. N., & Wilson, D. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)77254-2 · Cited by 976
Greenberg, P. D. (1991) · Advances in Immunology · doi:10.1016/s0065-2776(08)60778-6 · Cited by 603
A timeline of tumour-associated macrophage biology
Cassetta, L., & Pollard, J. W. (2023) · Nature Reviews Cancer · doi:10.1038/s41568-022-00547-1 · Cited by 581
MUC1, The Renaissance Molecule
Gendler, S. J. (2001) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1011379725811 · Cited by 552
Brossart, P., Wirths, S., Stuhler, G., Reichardt, V. L., Kanz, L., & Brugger, W. (2000) · Blood · doi:10.1182/blood.v96.9.3102 · Cited by 552
Fisk, B., Blevins, T. L., Wharton, J. T., & Ioannides, C. G. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.6.2109 · Cited by 543
Tumor Immunology and Tumor Evolution: Intertwined Histories
Galon, J., & Bruni, D. (2020) · Immunity · doi:10.1016/j.immuni.2019.12.018 · Cited by 540
Taylor-Papadimitriou, J., Burchell, J., Miles, D. W., & Dalziel, M. (1999) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(99)00055-1 · Cited by 465
Cancer antigens: immune recognition of self and altered self.
Houghton, A. N. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.1.1 · Cited by 420
Immune Reconstitution and Immunotherapy After Autologous Hematopoietic Stem Cell Transplantation
Guillaume, T., Rubinstein, D. B., & Symann, M. (1998) · Blood · doi:10.1182/blood.v92.5.1471 · Cited by 323
Serological identification of human tumor antigens
Sahin, U., Türeci, Ö., & Pfreundschuh, M. (1997) · Current Opinion in Immunology · doi:10.1016/s0952-7915(97)80053-2 · Cited by 315
Brossart, P., Heinrich, K. S., Stuhler, G., Behnke, L., Reichardt, V. L., Stevanovic, S., Muhm, A., Rammensee, H.-G., Kanz, L., & Brugger, W. (1999) · Blood · doi:10.1182/blood.v93.12.4309 · Cited by 306
Mucin-type O-glycosylation and its potential use in drug and vaccine development
Tarp, M. A., & Clausen, H. (2008) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2007.09.010 · Cited by 303
MUC1 mucin expression as a marker of progression and metastasis of human colorectal carcinoma
Nakamori, S., Ota, D. M., Cleary, K. R., Shirotani, K., & Irimura, T. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90592-4 · Cited by 280
Tumor Eradication by Adoptive Transfer of Cytototic T Lymphocytes
(1992) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60294-8 · Cited by 275
Understanding the drivers of MHC restriction of T cell receptors
La Gruta, N. L., Gras, S., Daley, S. R., Thomas, P. G., & Rossjohn, J. (2018) · Nature Reviews Immunology · doi:10.1038/s41577-018-0007-5 · Cited by 274
Delayed Mammary Tumor Progression in Muc-1 Null Mice
Spicer, A. P., Rowse, G. J., Lidner, T. K., & Gendler, S. J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.50.30093 · Cited by 266
Kimura, T., McKolanis, J. R., Dzubinski, L. A., Islam, K., Potter, D. M., Salazar, A. M., Schoen, R. E., & Finn, O. J. (2013) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-12-0275 · Cited by 263
Self-citationKaranikas, V, Hwang, L. A., Pearson, J., Ong, C. S., Apostolopoulos, V, Vaughan, H., Xing, P. X., Jamieson, G., Pietersz, G., Tait, B., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119825 · Cited by 263
MUC‐1 Epithelial Tumor Mucin‐Based Immunity and Cancer Vaccines
Finn, O. J., Jerome, K. R., Henderson, R. A., Pecher, G., Domenech, N., Magarian‐Blander, J., & Barratt‐Boyes, S. M. (1995) · Immunological Reviews · doi:10.1111/j.1600-065x.1995.tb00077.x · Cited by 261
Self-citationBilusic, M., Heery, C. R., Arlen, P. M., Rauckhorst, M., Apelian, D., Tsang, K. Y., Tucker, J. A., Jochems, C., Schlom, J., Gulley, J. L., et al. (2014) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-013-1505-8 · Cited by 102
“a modification of a previously described procedure [27, 28] was used to detect IFn-γ production in response to Cea peptide and/or tumor-associated antigen peptides MUC-1 [29], brachyury [30], and HIV (as control peptide).”
MethodInfluentialImmunological Evaluation of Recent MUC1 Glycopeptide Cancer Vaccines
Hossain, M., & Wall, K. (2016) · Vaccines · doi:10.3390/vaccines4030025 · Cited by 74
Metadata
- Authors
- Barnd, D. L., Lan, M. S., Metzgar, R. S., & Finn, O. J.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1989-09
- Volume
- 86
- Issue
- 18
- Pages
- 7159-7163
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1979397217
- Cited by
- 449
- References
- 13
- FWCI
- 6.30
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.